Janssen adds Astellas JAK inhibitor to its immunology portfolioPMLiVEAstellas will continue its in-house development of the drug for the prevention of organ transplant rejection, where the clinical programme has reached phase II. Meanwhile, Pfizer'…
Canadian University Press NewswireSTU student Heather MacInnis's road to recoveryCanadian University Press NewswireAfter a week of tests, they told her she had widespread infection, cellular rejection and potentially anti-body rejection. The doctor…
Luminex Corporation Participates in Community Initiatives to Save LivesSacramento BeeLaboratories around the world currently use Luminex xMAP Technology to match donors and transplant recipients, and to monitor post-transplant rejection. Human Leukocyt…
Luminex Corporation Participates in Community Initiatives to Save LivesRedOrbitLaboratories around the world currently use Luminex xMAP(®) Technology to match donors and transplant recipients, and to monitor post-transplant rejection. Human Leukocyte …
XDx Appoints Peter Maag as President and CEOThe Herald | HeraldOnline.comXDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive tests for the monitoring o…
The Next Big Niche? Emerging Med-Tech for Transplant.MedCity NewsMolecular diagnostics companies such as XDx are developing tests for non-invasively detecting early signs of transplant rejection, and predictive biomarkers for rejection predisposition a…
New Agents In Combination With Revlimid Show Promise For Relapsed …The Myeloma BeaconAfinitor is currently used to prevent transplant rejection and to treat some types of kidney cancers. Before 2010, there had been no research into the efficacy of Af…
NaharnetCuba Launches First NanopharmaceuticalNaharnetCuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. "Its main a…
Cuba launches first-ever nanopharmaceutical drugChina PostCuba launches first-ever nanopharmaceutical drug. HAVANA — Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplan…
Cuba launches first nanopharmaceuticalChannel News AsiaHAVANA: Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. "I…